DNAJC12: A Promising Drug Target for Neurological Disorders (G56521)

Target Name: DNAJC12

NCBI ID: G56521

DNAJC12

DNAJC12: A Promising Drug Target for Neurological Disorders

DNAJC12 (HPANBH4) is a protein that is expressed in various tissues throughout the body, including muscle, liver, and brain. It is a key regulator of the nervous system and has been implicated in a number of neurological and psychiatric disorders.

One of the most promising aspects of DNAJC12 is its potential as a drug target. Several studies have identified potential drug-like compounds that can interact with DNAJC12 and enhance its activity, suggesting that it may be a promising target for the treatment of a range of neurological and psychiatric disorders.

One of the key compounds that has been shown to interact with DNAJC12 is valproic acid, a compound that is commonly used as a treatment for epilepsy and bipolar disorder. Studies have shown that valproic acid can enhance the activity of DNAJC12 and increase the levels of the protein in brain cells.

Another potential drug that may interact with DNAJC12 is lithium, a compound that is commonly used as a treatment for bipolar disorder. Studies have shown that lithium can also enhance the activity of DNAJC12 and increase the levels of the protein in brain cells.

In addition to valproic acid and lithium, a number of other compounds have also been shown to interact with DNAJC12 and enhance its activity. These compounds include neurotransmitters, antidepressants, antipsychotics and hypnotics.

While the potential use of DNAJC12 as a drug target is an exciting area of 鈥嬧?媟esearch, it is important to note that the safety and effectiveness of any potential drug DNAJC12 must be carefully evaluated before it can be approved for use. Additionally, it is also important to consider the potential interactions of any drugs with DNAJC12 and other proteins in the body.

Overall, DNAJC12 is a protein that has the potential to be a drug target for the treatment of a range of neurological and psychiatric disorders. Further research is needed to fully understand its potential and to develop safe and effective drugs that can interact with DNAJC12.

Protein Name: DnaJ Heat Shock Protein Family (Hsp40) Member C12

The "DNAJC12 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about DNAJC12 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets